" 60.26 
final action on regulatory review period determinations. 
(a) fda will consider a regulatory review period determination to be final upon expiration of the 180-day period for filing a due diligence petition under  60.30 unless fda receives: 
(1) new information from pto records, fda records, or fda centers that affects the regulatory review period determination; 
(2) a request under  60.24 for revision of the regulatory review period determination; 
(3) a due diligence petition filed under  60.30; or 
(4) a request for a hearing filed under  60.40. 
(b) fda will notify pto that the regulatory review period determination is final upon: 
(1) the expiration of the 180-day period for filing a due diligence petition; or 
(2) if fda has received a request for a revision, a due diligence petition, or a request for a hearing, upon resolution of the request for a revision, the petition, or the hearing, whichever is later. fda will send a copy of the notification to the applicant and file a copy of the notification in the docket established for the application in fda's division of dockets management (hfa-305), 5630 fishers lane, rm. 1061, rockville, md 20852. 

